Delivery Order SPE2DB22D2006-SPE2DB24FW1SJ
Award Date
7/8/24
Potential Completion Date
7/9/24
Potential Value
$13K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of Gadavist, a medical contrast agent, in 30 ml vials. The award, valued at $1,140.90, is a firm fixed-price delivery order contract with a completion date of May 29, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,711.70 firm-fixed price delivery order is for the supply of Gadavist 7.5 MMol/7.5 ML vials, a medical imaging contrast agent. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,768.18 firm fixed-price delivery order is for the supply of the medication Gadavist, a vascular contrast agent used in medical imaging. The contract is not designated as a set-aside and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between Amerisourcebergen Drug Corp and the DLA Troop...
This federal contract award, with ID SPE2DB22D3004|SPE2DB24FPD77, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,361.96, is a delivery order for the supply of Gadavist 10 mmol/10 ml vial 10 ml, a pharmaceutical product. The award is not designated as a set-aside contract. It is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen Drug Corp holds...
This federal contract award, with ID SPE2DB22D1202|SPE2DB25FUSE0, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,201.52 firm fixed-price delivery order is for the supply of Gadavist, a medical imaging contrast agent, to support federal healthcare programs. The contract is not designated with any set-aside requirements, indicating open competition. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,260.26 firm fixed-price delivery order is for the supply of 30 ml bulk vials of the contrast agent Gadavist (1 mmol/ml). This delivery order falls under a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a wide range of pharmaceutical products and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,608.22 firm fixed price delivery order is for the supply of Gadavist, a medical imaging agent, with a completion date of May 30, 2023. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a...
This is a $2,912.40 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. The order is for Gadavist, a contrast agent used in medical imaging procedures. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, which provides a wide range of pharmaceutical and medical supplies to support military treatment programs...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,018.82, is for the delivery of Gadavist, a 15 mL vial of the contrast agent used in medical imaging procedures. This is a Firm Fixed Price Delivery Order contract with a completion date of February 14, 2025. The contract is not designated as a set-aside and appears to be part of a larger...
This federal contract award with ID SPE2DB20D1109|SPE2DB23FN32J was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,646.41 firm fixed-price delivery order is for the supply of 4559575870 - GADAVIST 10 MMOL/10 ML VIAL 10ML. The contract has a completion date of January 12, 2023 and was awarded on January 11, 2023. This delivery order is part of a larger $999,999,999 Indefinite Delivery...